Endemic Melioidosis in Tropical Northern Australia: A 10-Year Prospective Study and Review of the Literature

In a prospective study of melioidosis in northern Australia, 252 cases were found over 10 years. Of these, 46% were bacteremic, and 49 (19%) patients died. Despite administration of ceftazidime or carbapenems, mortality was 86% (43 of 50 patients) among those with septic shock. Pneumonia accounted f...

Full description

Saved in:
Bibliographic Details
Published inClinical infectious diseases Vol. 31; no. 4; pp. 981 - 986
Main Authors Currie, Bart J., Fisher, Dale A., Howard, Diane M., Burrow, James N. C., Lo, David, Selva-nayagam, Sid, Anstey, Nicholas M., Huffam, Sarah E., Snelling, Paul L., Marks, Paul J., Stephens, Diane P., Lum, Gary D., Jacups, Susan P., Krause, Vicki L.
Format Journal Article
LanguageEnglish
Published Chicago, IL The University of Chicago Press 01.10.2000
University of Chicago Press
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:In a prospective study of melioidosis in northern Australia, 252 cases were found over 10 years. Of these, 46% were bacteremic, and 49 (19%) patients died. Despite administration of ceftazidime or carbapenems, mortality was 86% (43 of 50 patients) among those with septic shock. Pneumonia accounted for 127 presentations (50%) and genitourinary infections for 37 (15%), with 35 men (18%) having prostatic abscesses. Other presentations included skin abscesses (32 patients; 13%), osteomyelitis and/or septic arthritis (9; 4%), soft tissue abscesses (10; 4%), and encephalomyelitis (10; 4%). Risk factors included diabetes (37%), excessive alcohol intake (39%), chronic lung disease (27%), chronic renal disease (10%), and consumption of kava (8%). Only 1 death occurred among the 51 patients (20%) with no risk factors (relative risk, 0.08; 95% confidence interval, 0.01–0.58). Intensive therapy with ceftazidime or carbapenems, followed by at least 3 months of eradication therapy with trimethoprim-sulfamethoxazole, was associated with decreased mortality. Strategies are needed to decrease the high mortality with melioidosis septic shock. Preliminary data on granulocyte colony-stimulating factor therapy are very encouraging.
Bibliography:istex:6CE5AF1C71E0F523247E8C5104D7289D882F9C6B
ark:/67375/HXZ-7CFDR980-H
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:1058-4838
1537-6591
DOI:10.1086/318116